Business Standard

CDSCO, states begin joint checks of drug-making units across India

Objective of drug regulation is to ensure safety, efficacy, and quality of drugs

A large drug firm has 12-15 therapy divisions, and if each launches a few drugs, the company brings to the market 30-50 brands a year.
Premium

Sohini Das Mumbai
Amid controversy surrounding India-made drugs that allegedly caused the deaths of children in the Gambia, the Central Drugs Standard Control Organisation (CDSCO) has started conducting inspections of identified drug manufacturing units jointly with state authorities across India.

The idea of the joint inspections is to ensure the safety, efficacy, and quality of drugs available in the country, the Union Ministry of Health said on Tuesday.

However, this is not the first time such widespread joint inspections have happened in India. 

Speaking to Business Standard, Navneet Marwaha, state drug controller of Himachal Pradesh (HP), said similar joint inspections were conducted in

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in